Found: 5000
Select item for more details and to access through your institution.
Editorial: Prognosis prediction and risk stratification in head and neck cancer .
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1037001
- By:
- Publication type:
- Article
Editorial: Therapies and influences in urothelial carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1126494
- By:
- Publication type:
- Article
Editorial: Molecular characteristics and personalized treatment for pediatric brain tumors.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1114280
- By:
- Publication type:
- Article
Higher radiation doses after partial laryngectomy may raise the incidence of pneumonia: A retrospective cohort study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1072474
- By:
- Publication type:
- Article
Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1014592
- By:
- Publication type:
- Article
Abdominoinguinal approach in en bloc resection of retroperitoneal sarcoma involving iliac vessels with graft interposition.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1040833
- By:
- Publication type:
- Article
Successful treatment of extensive-stage small cell lung cancer with concurrent pleural and pericardial effusions: Case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Case report: <sup>18</sup>F-FES PET/CT predicted treatment responses of second-line and third-line CDK4/6 inhibitors after disease progression on first-line CDK4/6 inhibitor in a HR+/HER2-metastatic breast cancer patient.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1095779
- By:
- Publication type:
- Article
Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.992455
- By:
- Publication type:
- Article
Advances in peptides encoded by non-coding RNAs: A cargo in exosome.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1081997
- By:
- Publication type:
- Article
Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1062065
- By:
- Publication type:
- Article
The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.956706
- By:
- Publication type:
- Article
Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1037742
- By:
- Publication type:
- Article
What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1067321
- By:
- Publication type:
- Article
Editorial: Awake surgery for brain tumors and brain connectomics.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1094818
- By:
- Publication type:
- Article
Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1041443
- By:
- Publication type:
- Article
Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.977664
- By:
- Publication type:
- Article
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.972322
- By:
- Publication type:
- Article
Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.975463
- By:
- Publication type:
- Article
Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma via EMT.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1052375
- By:
- Publication type:
- Article
Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1015264
- By:
- Publication type:
- Article
Frizzled receptors in melanomagenesis: From molecular interactions to target identification.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1096134
- By:
- Publication type:
- Article
Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1090544
- By:
- Publication type:
- Article
Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1063689
- By:
- Publication type:
- Article
Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1071100
- By:
- Publication type:
- Article
Detecting plasma hsa_circ_0061276 in patients with gastric cancer by reverse transcription-digital polymerase chain reaction.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1042248
- By:
- Publication type:
- Article
Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.951589
- By:
- Publication type:
- Article
Endoscopic endonasal resection of an epidermoid cyst in the cavernous sinus: A case report and literature review.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.972573
- By:
- Publication type:
- Article
A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.964508
- By:
- Publication type:
- Article
Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Cancer diagnosis in areas of conflict.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1087476
- By:
- Publication type:
- Article
Case Report: Multiple colorectal cancers in a patient with Ulcerative colitis and Lynch syndrome: Is there a role for prophylactic colectomy? A short report and review of literature.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1031606
- By:
- Publication type:
- Article
Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The role and mechanism of claudins in cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1051497
- By:
- Publication type:
- Article
Application of machine learning in the prediction of deficient mismatch repair in patients with colorectal cancer based on routine preoperative characterization.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1049305
- By:
- Publication type:
- Article
The reduction of <sup>18</sup>F-FDG uptake ability of tumor tissue after neoadjuvant chemoradiotherapy in locally advanced rectal cancer can effectively reflect the degree of tumor regression.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1037783
- By:
- Publication type:
- Article
Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma: A meta-analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1010726
- By:
- Publication type:
- Article
The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1076548
- By:
- Publication type:
- Article
A system based on deep convolutional neural network improves the detection of early gastric cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1021625
- By:
- Publication type:
- Article
Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1050288
- By:
- Publication type:
- Article
ENO1 contributes to 5-fluorouracil resistance in colorectal cancer cells via EMT pathway.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1013035
- By:
- Publication type:
- Article
Association of systemic inflammation index with survival in patients with advanced perihilar cholangiocarcinoma treated with interventional therapy.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1038759
- By:
- Publication type:
- Article
Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1106610
- By:
- Publication type:
- Article
Editorial: Advances in radiotherapy for prostate cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1122652
- By:
- Publication type:
- Article
Diagnostic and prognostic role of circulating neutrophil extracellular trap markers and prekallikrein in patients with high-grade serous ovarian cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.992056
- By:
- Publication type:
- Article
Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1077118
- By:
- Publication type:
- Article
Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1030802
- By:
- Publication type:
- Article
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1068981
- By:
- Publication type:
- Article
Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1026608
- By:
- Publication type:
- Article